Baxter International Inc. Faces Class Action Lawsuit

Baxter International Inc. is facing a class action lawsuit filed on behalf of investors who purchased common stock of the company between February 23, 2022, and July 30, 2025. The lawsuit claims that the company misleadingly disclosed the safety and efficacy of its Novum IQ Large Volume Pump, which suffered from systemic defects that caused malfunctions and exposed patients to risks of serious injury or death.

Key Takeaways:

• The lawsuit alleges that Baxter International Inc. failed to disclose the systemic defects of its Novum IQ Large Volume Pump, including underinfusion, overinfusion, and complete non-delivery of fluids.
• The company's attempts to address these defects through customer alerts were inadequate, and design flaws persisted and continued to cause serious harm to patients.
• Investors who purchased Baxter common stock during the Class Period may be entitled to compensation without payment of any out-of-pocket fees or costs.
• The lead plaintiff deadline is December 15, 2025, and those who wish to serve as lead plaintiff must move the court by this date.
• The Rosen Law Firm, a global investor rights law firm, is representing investors throughout the globe in securities class actions and shareholder derivative litigation.

Statistics:

• $438 million: The amount of money secured by the Rosen Law Firm for investors in 2019.
• 2017: The year in which the Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese company.
• 2020: The year in which founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar.
• 4 years: The number of years in which the Rosen Law Firm has been ranked in the top 4 for number of securities class action settlements.

Sources:

• Newsfile Corp. - October 29, 2025
• The Rosen Law Firm - Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc elementum ennato, elit nec convallis mollis, ex libero sodales ligula, et bibendum turpis justo at justo.